Results 111 to 120 of about 1,124 (174)

A Review of Clinical Trial and Meta-Analyses of BP Treatment Strategies for Patients with Orthostatic Hypotension: Blood Pressure Management in Patients with Hypertension and Orthostatic Hypotension. [PDF]

Curr Hypertens Rep
Rajesh S, Lee GR, Gao KJ, Verma A, Juraschek SP.   +4 more
europepmc   +1 more source

Midodrine to facilitate cardioprotective therapy in hypotensive HER2-positive breast cancer patients with cancer-therapy-related cardiac dysfunction-multicenter case experience. [PDF]

Cardiooncology
Koutroumpakis E, Iliescu C, Deswal A, Porter C.   +3 more
europepmc   +1 more source

Approaches for treating cardiovascular symptoms in Parkinson's disease. [PDF]

Ther Adv Neurol Disord
Jost WH, Koschel J.
europepmc   +1 more source

How to treat cardiovascular autonomic failure in Parkinson's disease. [PDF]

J Neural Transm (Vienna)
Fanciulli A, Leys F, Höglinger G, Jost WH.   +3 more
europepmc   +1 more source

Fludrocortisone for Refractory Hypotension in a Hospitalized Dialysis Patient: A Case Report. [PDF]

Cureus
Veerban F, Kurup M, Mohamed I, Salifu M, McFarlane SI, Azhar M, Puri I, Mallappallil M.   +7 more
europepmc   +1 more source

Editorial: Enzyme targeting for the development of novel antimicrobials. [PDF]

Front Mol Biosci
Salina EG, Qiao C, Chiarelli LR.
europepmc   +1 more source

Decreased urinary excretion of norepinephrine and dopamine in autonomic synucleinopathies. [PDF]

Clin Auton Res
Goldstein DS, Sullivan P, Holmes C.
europepmc   +1 more source

Droxidopa reduces postural sway in Parkinson disease patients with orthostatic hypotension

Parkinsonism and Related Disorders, 2022
We evaluate the effect of droxidopa on gait and balance measures in nine patients with Parkinson's disease and neurogenic orthostatic hypotension. Computerized gait/balance analysis showed a significant effect of droxidopa in reducing postural sway ...
Andrea Sturchio, Isabella Premoli, Alberto J. Espay   +2 more
exaly   +2 more sources

DBH deficiency in an elderly patient: efficacy and safety of chronic droxidopa

Clinical Autonomic Research, 2010
International audienceWe describe the effects of chronic droxidopa in a patient with Dopamine beta-hydroxylase deficiency diagnosed at the age of 73. Investigations were performed to assess sympathetic activity (MIBG scintigraphy, catecholamines) and ...
Fabien Despas, M Galinier, J M Senard
exaly   +2 more sources